The European Association for Cancer Research (EACR), American Association for Cancer Research (AACR) and Società Italiana di Cancerologia (SIC) are proud to announce this new joint Basic and Translational Research Conference that gathers top experts in the fields of Immunology and DNA Damage in Florence, Italy to discuss the molecular mechanisms laying at the convergence of these two research fields and how they can be exploited to treat cancer.
The integrity of DNA molecules is vital for proper cellular function, yet it is under constant assault from environmental and metabolic DNA damaging agents. Failure to maintain faithful DNA replication and as such genome stability and integrity leads to DNA lesions and mutations that are a driving factor in tumour initiation and progression. Cancer development is further modulated by the immune response.
More recent research has uncovered a role for DNA repair mechanisms beyond tumorigenesis. It is now known that DNA repair is at the core of regulating the balance between tumour progression and immune response, and as such can predict the efficacy of immunotherapy.
The target audience for this conference is basic and translational scientists, both senior and young investigators with an interest in DNA damage and repair mechanisms and/ or Cancer Immunology and Immunotherapy, as well as clinicians with an interest in cancer immunotherapy including those involved in the development of novel therapeutic approaches to treatment.
Abstract Submission Deadline
21 November 2022
Bursary Application Deadline
21 November 2022
Early Bird Registration Deadline
13 January 2023
Regular Rate Registration Deadline
28 February 2023
Full Rate Registration Deadline
15 March 2023
Follow along on social media and engage with the event using #EASImmuneResponses
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.